Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Drug and Alcohol Review|April 12, 2017
Scotland's national naloxone program: The prison experienceKirsten Horsburgh, Andrew McAuley
Addiction (Abingdon, England)|October 22, 2024
Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011-2020: A national retrospective cohort studyRosalyn Fraser, Alan Yeung, Megan Glancy, et al.
The International Journal on Drug Policy|July 6, 2025
Risk of drug-related mortality among people receiving opioid-agonist treatment during the COVID-19 pandemic in ScotlandMegan Glancy, Andrew McAuley, Norah Palmateer, et al.
Harm Reduction Journal|February 20, 2025
Impact of UNODC/WHO S-O-S (stop-overdose-safely) training on opioid overdose knowledge and attitudes among people at high or low risk of opioid overdose in Kazakhstan, Kyrgyzstan, Tajikistan and UkrainePaul Dietze, Samantha Colledge-Frisby, Gilberto Gerra, et al.
BMC Public Health|August 23, 2023
A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORSNicola Metrebian, Ben Carter, Desiree Eide, et al.
Addiction (Abingdon, England)|April 17, 2024
Prevalence of opioid dependence in Scotland 2015-2020: A multi-parameter estimation of prevalence (MPEP) studyAndreas Markoulidakis, Matthew Hickman, Andrew McAuley, et al.
Addiction (Abingdon, England)|July 13, 2026
Overdose reversal through peer intervention: Findings from the naloxone prospective outcome research study (NalPORS) on the effectiveness of overdose response by people who use opioids in the United Kingdom and SwedenNicola Metrebian, Teodora Dascal, Clare Mackie, et al.
The International Journal on Drug Policy|July 19, 2022
A rapid assessment of take-home naloxone provision during COVID-19 in EuropeRebecca McDonald, Desiree Eide, Katri Abel-Ollo, et al.
Pageof 1